Reverse Triple Negative Immune Resistant Breast Cancer

Clinical trial NCT05076682 · RECRUITING

Trial details

NCT number: NCT05076682
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Triple-negative Breast Cancer

Start date: 2022-06-30
Primary completion: 2026-12-31
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.